- Editorial
755 Views
1 Page
In This Issue of Current Oncology
- M. McLean
This issue of Current Oncology, the fifth of six issues scheduled for 2007 [...]
- 3.4Impact Factor
- 4.9CiteScore
- 22 daysTime to First Decision
- Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Current Oncology, Volume 14, Issue 5
October 2007 - 9 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles (9)
- Erratum
1 Page
An incorrect table was submitted earlier this year as part of the article “Canadian recommendations for the treatment of glioblastoma multiforme” [...]
- Article
3 Citations
928 Views
2 Pages
Radiation Oncology: Times of Practice Change
- Carolyn R. Freeman and
- E. B. Podgorsak
Developments in radiotherapy during the past 10–15 years, which have been driven largely by technological advances, have been nothing short of remarkable. Significant advances in tumour imaging, in radiotherapy treatment planning, and in dose deliver...
- Article
7 Citations
1,484 Views
6 Pages
Cancer Antigen 125 in Ovarian Cancer Surveillance: A Decision Analysis Model
- M. Laura Hopkins,
- D. Coyle,
- T. Le,
- M. Fung Kee Fung and
- G. Wells
We used decision analysis techniques with Markov cohort modeling to examine the role of cancer antigen 125 (CA-125) in follow-up surveillance strategies among patients with advanced ovarian cancer. Utilities were derived from a societal perspective....
- Article
206 Citations
5,054 Views
7 Pages
Symptom Clusters in Cancer Patients: A Review of the Literature
- G. Fan,
- L. Filipczak and
- Edward Chow
Cancer patients often experience multiple symptoms, and those symptoms can independently predict changes in patient function, treatment failures, and post-therapeutic outcomes. Symptom clusters are defined as two or more concurrent symptoms that are...
- Article
46 Citations
2,280 Views
9 Pages
Treatment of Depression in Cancer Patients
- G. Rodin,
- M. Katz,
- N. Lloyd,
- E. Green,
- J. A. Mackay,
- R. K. S. Wong and
- the Supportive Care Guidelines Group of Cancer Care Ontario’s Program in Evidence-Based Care
Question: What is the efficacy of pharmacologic and non-pharmacologic treatments for major depression and other depressive disorders in cancer populations? Perspectives: Depression occurs at an increased rate in medically ill populations, including p...
- Article
178 Citations
3,110 Views
6 Pages
Gliadel Wafers in the Treatment of Malignant Glioma: A Systematic Review
- James Perry,
- A. Chambers,
- K. Spithoff,
- N. Laperriere and
- on behalf of the Neuro-Oncology Disease Site Group§ of Cancer Care Ontario’s Program in Evidence-Based Care
Question: What is the safety and efficacy of interstitial chemotherapy with carmustine-loaded polymers (Gliadel wafers: MGI Pharma, Bloomington, MN, U.S.A.) in the treatment of newly diagnosed or recurrent malignant glioma (that is, glioblastoma mult...
- Article
207 Citations
3,635 Views
14 Pages
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
- M. Fung-Kee-Fung,
- T. Oliver,
- L. Elit,
- A. Oza,
- H. W. Hirte,
- P. Bryson and
- on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
Question: What is the optimal chemotherapy treatment for women with recurrent ovarian cancer who have previously received platinum-based chemotherapy? Perspectives: Currently, standard primary therapy for advanced disease involves a combination of ma...
- Article
17 Citations
1,228 Views
9 Pages
Canadian Supportive Care Recommendations for the Management of Anemia in Patients with Cancer
- J. Mikhael,
- B. Melosky,
- C. Cripps,
- D. Rayson and
- C. T. Kouroukis
Anemia is a common finding in cancer patients, most often as a result of chemotherapy. Management of anemia requires a comprehensive approach of appropriate diagnosis, exclusion of reversible causes, use of erythropoiesis-stimulating agents (esas), a...
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Curr. Oncol. - ISSN 1718-7729